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ABSTRACT 
Blood fatty acids (FAs) are derived from endogenous and dietary routes. Metabolic 
abnormalities from kidney dysfunction, as well as cross-cultural dietary habits, may alter the 
FA profile of dialysis patients (DP), leading to detrimental clinical outcomes. Therefore, we 
aimed to (i) summarize FA status of DP from different countries, (ii) compare blood FA 
composition between healthy controls and DP, and (iii) evaluate FA profile and clinical 
endpoints in DP. Fifty-three articles from 1980 onwards, reporting FA profile in hemodialysis 
and peritoneal DP, were identified from PubMed, Embase, and the Cochrane library. Studies 
on pediatric, predialysis chronic kidney disease, acute kidney injury, and transplant patients 
were excluded. Moderate to high levels of n-3 polyunsaturated fatty acids (PUFA) were 
reported in Japan, Korea, Denmark, and Sweden. Compared to healthy adults, DP had lower 
proportions of n-3 and n-6 PUFA, but higher proportion of monounsaturated fatty acids. Two 
studies reported inverse associations between n-3 PUFAs and risks of sudden cardiac death, 
while one reported eicosapentaenoic acid + docosahexaenoic acid)/arachidonic acid ratio was 
inversely associated with cardiovascular events. The relationship between all-cause mortality 
and blood FA composition in DP remained inconclusive. The current evidence highlights a 
critical role for essential FA in nutritional management of DP. 
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